raw materials – Page 2

Potential nitrosamine source identified during supplier audit – preventing product recall

Addressing Potential Nitrosamine Sources Uncovered in Supplier Audits With increasing scrutiny around nitrosamine impurities, manufacturers face growing pressure to ensure that their raw materials meet strict regulatory guidelines. A recent…

FIFO not followed during inventory reconciliation – product quality impact assessment

Assessing the Impact of FIFO Non-Compliance During Inventory Reconciliation In the pharmaceutical industry, adherence to inventory management procedures, particularly the First In, First Out (FIFO) principle, is critical in maintaining…

Risk mitigation plan inadequate during submission support – risk mitigation and control strategy

Effective Strategies for Inadequate Risk Mitigation During Submission Support In the evolving landscape of pharmaceutical manufacturing, ensuring rigorous risk management, particularly during submission support phases, is critical. An inadequate risk…

Improper segregation of materials during warehouse operations – inspection defense documentation

Exploring the Investigation of Improper Material Segregation in Warehouse Operations In pharmaceutical manufacturing, proper segregation of materials in warehouses is critical to maintaining product integrity and ensuring compliance with regulatory…

Nitrosamine risk assessment incomplete during ongoing surveillance – risk mitigation and control strategy

Navigating Incomplete Nitrosamine Risk Assessments During Ongoing Surveillance: A Practical Playbook Nitrosamines, particularly in pharmaceutical manufacturing, have emerged as critical components of risk assessment strategies due to regulatory pressures from…

Labeling deficiencies during inventory reconciliation – inspection defense documentation

Investigating Labeling Deficiencies in Inventory Reconciliation for Effective Inspection Defense Labeling deficiencies during inventory reconciliation can lead to serious compliance issues, potentially affecting product quality, safety, and regulatory standing. This…

Risk mitigation plan inadequate during regulatory inspection – CAPA for nitrosamine findings

Developing an Effective Risk Mitigation Plan for Nitrosamine Findings During Regulatory Inspections As the pharmaceutical industry navigates increasing scrutiny regarding nitrosamine contamination, professionals across manufacturing and quality sectors must ensure…

Labeling deficiencies during warehouse operations – product quality impact assessment

Addressing Labeling Errors in Warehouse Operations: A Comprehensive Quality Impact Assessment Pharmaceutical manufacturing relies heavily on effective warehouse operations, especially regarding the management of raw materials and excipients. One of…

Supplier nitrosamine control weak during regulatory inspection – CAPA for nitrosamine findings

Enhancing Supplier Nitrosamine Control for Regulatory Inspections Nitrosamines pose a significant risk in pharmaceutical manufacturing, particularly concerning raw materials. A recent increase in regulatory scrutiny has revealed that many organizations…

Storage condition excursion during inspection walkthrough – inspection defense documentation

Investigating Storage Condition Excursions During Inspection Walkthroughs Storage condition excursions present significant compliance and quality assurance challenges in pharmaceutical manufacturing. This article outlines a systematic investigation approach to identify root…

Analytical method sensitivity questioned during ongoing surveillance – risk mitigation and control strategy

As pharmaceutical manufacturing operations intensify scrutiny due to evolving regulations and compliance landscapes, analytical method sensitivity has emerged as a critical concern. This issue is particularly acute in the context…

Expired material used during routine checks – CAPA for warehouse failures

Addressing the Use of Expired Materials During Routine Quality Checks in Pharma Warehouses In pharmaceutical manufacturing, the integrity of raw materials is paramount to ensuring product quality and compliance with…